Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Ned Tijdschr Geneeskd ; 1672023 02 13.
Article in Dutch | MEDLINE | ID: mdl-36861652

ABSTRACT

A self-test suffices for the diagnosis SARS-CoV-2 infection in the Netherlands since 11 April 2022. Yet, selected groups such as health care workers can still divert to the Public Health Services (PHS) SARS-CoV-2 testing facilities for a nucleic acid amplification test. A survey among 2257 subjects visiting PHS Kennemerland testing sites demonstrates that the majority of participants does however not belong to one of the selected groups. Most subjects visit the PHS to confirm the result of their home test. The infrastructure and personnel needed to maintain the PHS testing sites come at high costs, which are in striking contrast to the government objectives and the low number of current visitors. The Dutch covid-19 testing policy therefore urgently needs revision.


Subject(s)
COVID-19 Testing , COVID-19 , United States , Humans , COVID-19/diagnosis , SARS-CoV-2 , Ethnicity , Policy
2.
Diagnostics (Basel) ; 13(3)2023 Jan 18.
Article in English | MEDLINE | ID: mdl-36766452

ABSTRACT

BACKGROUND: Oropharyngeal (OP) and nasopharyngeal (NP) sampling has historically been considered the reference specimen type used for respiratory virus detection. Saliva could be a less invasive alternative for SARS-CoV-2 detection, but limited evidence is available. METHODS: The technical and clinical performance of saliva was compared to OP/NP on the Hologic Panther platform with two Aptima assays, the End-Point Transcription-Mediated Amplification assay (EP-TMA) and Real-Time Transcription-Mediated Amplification assay (RT-TMA). The samples were collected at the Public Health Service Testing Site XL location in Schiphol Amsterdam Airport. At the site, the Regional Public Health Laboratory Kennemerland (RPHLK) has a fully equipped laboratory facility. RESULTS: A total of 374 samples (187 OP/NP swabs and 187 saliva samples) were collected from 187 unique patients. The Real-Time Transcription-Mediated Amplification assay (RT-TMA) resulted in comparable sensitivities for the detection of SARS-CoV-2 in both the OP/NP swabs (88.3%; 113/128) and saliva samples (87.5%; 112/128). The End-Point Transcription-Mediated Amplification assay (EP-TMA) analyses showed a similar sensitivity (86.7%; 111/128) in the OP/NP swabs but a lower sensitivity in the saliva samples (80.5%; 103/128). Within the discordant analyses, we found no associations in the symptoms, earlier SARS-CoV-2 infections and eating, smoking, drinking and tooth brushing habits within one hour before testing. CONCLUSIONS: The Hologic Panther platform Real-Time Transcription-Mediated Amplification assay (RT-TMA) yields a sensitivity for the detection of SARS-CoV-2 in saliva that is comparable to the OP/NP swabs derived from participants presenting themselves at a public health testing facility with minimal or mild symptoms.

3.
Open Forum Infect Dis ; 9(7): ofac223, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35821732

ABSTRACT

Background: We assessed the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load and hospital admission, intensive care unit (ICU) admission, and in-hospital mortality. Methods: All SARS-CoV-2-positive persons with a combined nasopharyngeal and oropharyngeal swab that was collected between 17 March 2020 and 31 March 2021 in public health testing facilities were included. Results: From 20 207 SARS-CoV-2-positive persons, 310 (1.5%) were hospitalized within 30 days. High viral loads (crossing point [Cp] <25) were associated with an increased risk of hospitalization as compared to low viral loads (Cp >30), adjusted for age and sex (adjusted odds ratio [aOR], 1.57 [95% confidence interval {CI}, 1.11-2.26]). The same association was seen for ICU admission (aOR, 7.06 [95% CI, 2.15-43.57]). The median [interquartile range] Cp value of the 17 patients who died in hospital was significantly lower compared to the 226 survivors (22.7 [3.4] vs 25.0 [5.2]). Conclusions: Higher initial SARS-CoV-2 viral load is associated with an increased risk of hospital admission, ICU admission, and in-hospital mortality. Our findings emphasize the added value of reporting SARS-CoV-2 viral load or cycle threshold/Cp values to identify persons who are at the highest risk of adverse outcomes such as hospital or ICU admission and who therefore may benefit from more intensive monitoring or early initiation of antiviral therapy.

4.
Diagnostics (Basel) ; 12(3)2022 Mar 15.
Article in English | MEDLINE | ID: mdl-35328272

ABSTRACT

BACKGROUND: We assessed the SARS-CoV-2 reinfection rate in a large patient cohort, and evaluated the effect of varying time intervals between two positive tests on assumed reinfection rates using viral load data. METHODS: All positive SARS-CoV-2 samples collected between 1 March 2020 and 1 August 2021 from a laboratory in the region Kennemerland, the Netherlands, were included. The reinfection rate was analyzed using different time intervals between two positive tests varying between 2 and 16 weeks. SARS-CoV-2 PCR crossing point (Cp) values were used to estimate viral loads. RESULTS: In total, 679,513 samples were analyzed, of which 53,366 tests (7.9%) were SARS-CoV-2 positive. The number of reinfections varied between 260 (0.52%) for an interval of 2 weeks, 89 (0.19%) for 4 weeks, 52 (0.11%) for 8 weeks, and 37 (0.09%) for a minimum interval of 16 weeks between positive tests. The median Cp-value (IQR) in the second positive samples decreased when a longer interval was chosen, but stabilized from week 8 onwards. CONCLUSIONS: Although the calculated reinfection prevalence was relatively low (0.11% for the 8-week time interval), choosing a different minimum interval between two positive tests resulted in major differences in reinfection rates. As reinfection Cp-values stabilized after 8 weeks, we hypothesize this interval to best reflect novel infection rather than persistent shedding.

6.
J Travel Med ; 18(6): 425-6, 2011.
Article in English | MEDLINE | ID: mdl-22017722

ABSTRACT

A 54-year-old woman presented with 2 weeks of fever after a trip to the Northeastern United States. Except for an erythematous skin lesion on her right shoulder, no physical abnormality was detected. We diagnosed concomitant borreliosis and babesiosis. Both infections were possibly acquired by one bite from Ixodes scapularis.


Subject(s)
Babesiosis/ethnology , Bites and Stings/enzymology , Borrelia burgdorferi/isolation & purification , Ixodes/microbiology , Lyme Disease/ethnology , Animals , Babesiosis/complications , Babesiosis/microbiology , Bites and Stings/complications , Bites and Stings/microbiology , Female , Humans , Indonesia/ethnology , Lyme Disease/complications , Lyme Disease/microbiology , Middle Aged , New England/epidemiology
7.
Scand J Infect Dis ; 43(10): 821-6, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21563880

ABSTRACT

We present 2 human immunodeficiency virus-infected patients with tenofovir disoproxil fumarate-induced Fanconi syndrome, leading to osteomalacia. Intracellular tenofovir diphosphate levels were measured in 1 patient and were found to be very high, with plasma tenofovir levels just slightly elevated. Fibroblast growth factor-23, a phosphaturic hormone, was decreased in both patients and is therefore unlikely to have a pathophysiological role in this pathology. The different potential factors contributing to the development of tenofovir-related kidney proximal tubular dysfunction are discussed and the data presented may help to further elucidate its pathogenesis.


Subject(s)
Adenine/analogs & derivatives , Anti-HIV Agents/adverse effects , Fanconi Syndrome/chemically induced , HIV Infections/drug therapy , Organophosphonates/adverse effects , Osteomalacia/chemically induced , Adenine/adverse effects , Adenine/blood , Adenine/therapeutic use , Adult , Anti-HIV Agents/therapeutic use , Diphosphates/blood , Fanconi Syndrome/diagnosis , Fanconi Syndrome/diagnostic imaging , Fanconi Syndrome/virology , HIV Infections/complications , Humans , Male , Middle Aged , Organophosphonates/blood , Organophosphonates/therapeutic use , Osteomalacia/diagnosis , Osteomalacia/virology , Radionuclide Imaging , Tenofovir , Whole Body Imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...